C4

Back

CLINICAL SIGNIFICANCE
Increased levels of C4 in serum are observed in some patients with a variety of malignancies. Deficiency of C4 is observed in autoimmune hemolytic anemia, proliferative glomerulonephritis, certain cryoglobulinemias, rheumatoid arthritis, Sjogren’s syndrome, neonatal respiratory distress syndrome, SLE, hereditary angioedema, infectious endocarditis with secondary glomerulonephritis.
CHARACTERISTICS

Form: Liquid ready-to-use
Shelf life: 18 months @ 2-8 C
On-Board Stability: 60 days
Sample: Serum or plasma with EDTA
Detection limit: 0.6 mg/dL
Linearity: 1.6-120 mg/dL


Packaging
For Use On
MEDILYZER
EX-OLYMPUS
GENERAL PURPOSE
SIEMENS ADVIA
Packaging
4x40 Tests & 4x90 Tests
4x25 Tests & 4x100 Tests
R1 3x100, R2 75
4x80 Tests & 4x180 Tests